Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengwei Peng

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2025
Fertility counseling in early-onset colorectal cancer and the impact of patient characteristicsChengwei Peng, Dalia Littman, Lena Masri, et al.
Gene|August 30, 2020
Circ_0005075 targeting miR-151a-3p promotes neuropathic pain in CCI rats via inducing NOTCH2 expressionYuwen Zhang, Tao Gao, Xuan Li, et al.
Cancer Immunology Research|May 20, 2016
Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent PembrolizumabAmanda Shreders, Richard Joseph, Chengwei Peng, et al.
ACG Case Reports Journal|November 22, 2019
Graft-Versus-Host Disease After Pancreatic TransplantationSaad Saffo, Chengwei Peng, Nour Kibbi, et al.
ACG Case Reports Journal|June 1, 2026
An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor TherapyNoah Lybik, Benjamin D Liu, Joseph R Fuchs, et al.
Molecular and Clinical Oncology|February 20, 2016
Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experienceChengwei Peng, Jialing Wang, Jarred P Tanksley, et al.
Scientific Reports|February 17, 2017
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF InhibitionKeisha N Hardeman, Chengwei Peng, Bishal B Paudel, et al.
The Oncologist|May 13, 2015
Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective ReviewDouglas B Johnson, Chengwei Peng, Richard G Abramson, et al.
Frontiers in Oncology|May 20, 2026
Ultra-sensitive detection of mutant <i>KRAS</i> in circulating tumor DNA predicts survival in resectable pancreatic adenocarcinomaMadison Cox, Amy Wells, Dominic Vitello, et al.
Msystems|February 27, 2025
Association of tumor microbiome with survival in resected early-stage PDACYixuan Meng, Chan Wang, Mykhaylo Usyk, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2025
Fertility counseling in early-onset colorectal cancer and the impact of patient characteristicsChengwei Peng, Dalia Littman, Lena Masri, et al.
Gene|August 30, 2020
Circ_0005075 targeting miR-151a-3p promotes neuropathic pain in CCI rats via inducing NOTCH2 expressionYuwen Zhang, Tao Gao, Xuan Li, et al.
Cancer Immunology Research|May 20, 2016
Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent PembrolizumabAmanda Shreders, Richard Joseph, Chengwei Peng, et al.
ACG Case Reports Journal|November 22, 2019
Graft-Versus-Host Disease After Pancreatic TransplantationSaad Saffo, Chengwei Peng, Nour Kibbi, et al.
ACG Case Reports Journal|June 1, 2026
An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor TherapyNoah Lybik, Benjamin D Liu, Joseph R Fuchs, et al.
Molecular and Clinical Oncology|February 20, 2016
Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experienceChengwei Peng, Jialing Wang, Jarred P Tanksley, et al.
Scientific Reports|February 17, 2017
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF InhibitionKeisha N Hardeman, Chengwei Peng, Bishal B Paudel, et al.
The Oncologist|May 13, 2015
Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective ReviewDouglas B Johnson, Chengwei Peng, Richard G Abramson, et al.
Frontiers in Oncology|May 20, 2026
Ultra-sensitive detection of mutant <i>KRAS</i> in circulating tumor DNA predicts survival in resectable pancreatic adenocarcinomaMadison Cox, Amy Wells, Dominic Vitello, et al.
Msystems|February 27, 2025
Association of tumor microbiome with survival in resected early-stage PDACYixuan Meng, Chan Wang, Mykhaylo Usyk, et al.
Pageof 3